BICO.ST Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 18:29):

BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation...

Stats
Dzisiejszy wolumen	110 037
Średni wolumen	327 951
Kapitalizacja rynkowa	3.15B
EPS	SEK0 ( 2024-02-19 )
Następna data zysków	( SEK-0.710 ) 2024-05-06
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-1.900
ATR14	SEK0.151 (0.33%)

Wolumen Korelacja

Długi: -0.15 (neutral)

Krótki: -0.97 (very strong negative)

Signal:(56.555) Neutral

BICO Group AB (publ) Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BICO Group AB (publ) Korelacja - Waluta/Towar

-0.27
( neutral )

-0.04
( neutral )

0.00
( neutral )

-0.29
( neutral )

-0.11
( neutral )

-0.12
( neutral )

BICO Group AB (publ) Finanse

Annual	2022
Przychody:	SEK2.24B
Zysk brutto:	SEK1.83B (81.74 %)
EPS:	SEK-12.99

FY	2022
Przychody:	SEK2.24B
Zysk brutto:	SEK1.83B (81.74 %)
EPS:	SEK-12.99

FY	2021
Przychody:	SEK1.26B
Zysk brutto:	SEK1.00B (79.72 %)
EPS:	SEK-3.97

FY	2020
Przychody:	SEK176.79M
Zysk brutto:	SEK163.62M (92.55 %)
EPS:	SEK-1.500

Financial Reports:

No articles found.

BICO Group AB (publ)

BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.